**1. Introduction**

Neonatal meningitis continues to retain its importance all over the world as an infectious disease because of its morbidity. Medical facilities that enable physicians to keep more and more premature infants alive in economically developed countries and, on the contrary side, limitations in access to healthcare systems in economically developing countries keep neonatal meningitis on the medical agenda in an era of highly developed antimicrobial management and immunization.
